HTDS helps fight Sickle cell disease

22 June 2020 ─  /  Analytical Sciences  by Sarra

On Friday, June 19, World Sickle Cell Disease Day was held.

 

Sickle cell disease is an inherited hemoglobin disease and is also, unfortunately, the most widespread genetic disease in the world. It particularly affects certain geographical areas such as the Mediterranean basin, where the abnormal hemoglobin S does not fully play its role as an oxygen carrier.

 

Its sickle-like shape makes it fragile and makes it difficult for it to circulate in the blood. Diagnosis can be made by means of a CBC, PCR analysis, liquid chromatography and capillary electrophoresis for example.

 

This World Day is an opportunity to inform the general public and warn them of the most common clinical aspects. Dedicated to what is also known as sickle-cell anemia, it also aims to raise awareness of neonatal screening.

 

From the very first weeks, this allows preventive measures to be put in place by detecting or not detecting the S mutation of the gene coding for beta-globin. Discover our screening solution: https://bit.ly/2YSIjXE

 

Our experts are at your disposal to help you choose the solution adapted to your organization. To better fight against the disease, contact us!

Read also...

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

23 September 2025

Analytical Sciences

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

HTDS is pleased to announce the signing of a strategic partnership with Oxford Nanopore Technologies, a UK-based company that is a pioneer and globally recognized for its DNA and RNA sequencing solutions. This new agreement allows HTDS to strengthen its portfolio of analytical solutions and offer its customers a breakthrough technology that is transforming genomic and biological research. Oxford Nanopore : a unique technology to analyze lifeWith the mission to enable “the analysis of anything, by anyone, anywhere”, Oxford Nanopore has developed an innovative sequencing technology based on nanopores.This approach provides researchers and industry professionals with real-time, accurate, flexible, and scalable nucleic acid analysis, opening new perspectives in: Plant and animal genomicsAgriculture and food sciencesEnvironmental research and conservationAlready adopted in more than 125 countries, this technology is revolutionizing our understanding of life and accelerating scientific progress. A complete range of solutions tailored to every projectThrough this partnership, HTDS now distributes the entire Oxford Nanopore portfolio, covering all needs, from individual research to large-scale projects:MinION™ : a portable, personal sequencer, ideal for generating rapid data directly in the field or in the lab.GridION™ : a flexible benchtop sequencer, integrating data processing for multiple simultaneous analyses.PromethION™ (P2 Solo, P2 Integrated, PromethION 24) : a high-throughput platform for projects requiring massive volumes of genomic data.ElysION™ : a fully automated solution, from sample preparation to data analysis.In addition to these platforms, Oxford Nanopore provides a complete sequencing ecosystem, including flow cells and sample preparation kits, as well as control and analysis software such as MinKNOW™ and EPI2ME™, making sequencing accessible even to researchers without bioinformatics expertise. HTDS : a trusted partner for your genomics projectsBy partnering with Oxford Nanopore, HTDS reaffirms its commitment to offering its customers the most innovative technologies to meet their scientific and industrial needs.Research laboratories, academic centers, and industry players will now benefit from powerful, scalable, and tailored tools to address today’s challenges in genomics, health, and the environment.